insitro raises $400M Series C led by CPP Investments

insitro

insitro raised $400 million in a Series C led by Canada Pension Plan Investment Board (CPP Investments), with backing from Andreessen Horowitz, T. Rowe Price, Casdin, BlackRock, ARCH, and GV. The funding supports insitro's machine-learning approach to pairing large biological datasets with AI to find drug targets.

• CPP Investments joined the company's board; the round reflects investor confidence in machine learning for drug discovery.
• insitro already had partnerships with Gilead and Bristol Myers Squibb.
• Investors also included Third Rock Ventures, Two Sigma, HOF Capital, Alexandria Venture Investments, Temasek, and SoftBank.